You are here

patient deaths

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths

Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths

BioSpace

X-linked myotubular myopathy

Flag link:

ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear

ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear

Fierce Biotech

clinical trials

non-small cell lung cancer

Flag link:

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study

BioSpace

clinical trials

Duchenne Muscular Dystrophy

Flag link:

FDA puts 2seventy CAR-T trial on hold in wake of patient death

FDA puts 2seventy CAR-T trial on hold in wake of patient death

Fierce Biotech

clinical trials

Flag link:

Abiomed’s Impella Now Linked to 4 Deaths in Recent Recall

Abiomed’s Impella Now Linked to 4 Deaths in Recent Recall

Medical Devices and Diagnostics Industry

Flag link:

Regeneron rethinks CD28 bispecific R&D plan after 2 patients die

Regeneron rethinks CD28 bispecific R&D plan after 2 patients die

Fierce Biotech

prostate cancer

clinical trials

bispecific antibodies

Flag link:

ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths

ADC Therapeutics Halts Enrollment of Zynlonta Trial After Seven Patient Deaths

BioSpace

ADC Therapeutics

clinical trials

diffuse large B-cell lymphoma

Flag link:

DMD gene therapy death exposes risks of treating older patients

DMD gene therapy death exposes risks of treating older patients

Fierce Biotech

Cure Rare Disease

clinical trials

Flag link:

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin

Fierce Pharma

Flag link:

Patient death spurs trial halt for Magenta Therapeutics

Patient death spurs trial halt for Magenta Therapeutics

Endpoints

Magenta Therapeutics

clinical trials

myelodysplastic syndrome

Flag link:

3rd patient death potentially tied to Eisai's Alzheimer's drug reported

3rd patient death potentially tied to Eisai's Alzheimer's drug reported

Fierce Biotech

Alzheimer's disease

clinical trials

Flag link:

Only Patient in N-of-1 CRISPR Trial for Duchenne Muscular Dystrophy Dies

Only Patient in N-of-1 CRISPR Trial for Duchenne Muscular Dystrophy Dies

BioSpace

clinical trials

Duchenne Muscular Dystrophy

Flag link:

Medtronic reports six more injuries, one additional death related to HVAD battery problems

Medtronic reports six more injuries, one additional death related to HVAD battery problems

Medtech Dive

Flag link:

Novartis reports deaths of two patients treated with Zolgensma gene therapy

Novartis reports deaths of two patients treated with Zolgensma gene therapy

BioPharma Dive

spinal muscular atrophy

Flag link:

MacroGenics closes solid tumor clinical trial after 7 people die

MacroGenics closes solid tumor clinical trial after 7 people die

Fierce Biotech

clinical trials

Flag link:

Philips investigates reports of 1 death, 4 injuries potentially tied to ventilator recall

Philips investigates reports of 1 death, 4 injuries potentially tied to ventilator recall

Medtech Dive

Respironics V60 ventilator

Flag link:

FDA puts Curis' leukemia trial on partial hold after patient death spurs review of muscle breakdown

FDA puts Curis' leukemia trial on partial hold after patient death spurs review of muscle breakdown

Fierce Biotech

clinical trials

acute myeloid leukemia

Flag link:

Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy

Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy

Fierce Biotech

Alpine Immune Sciences

clinical trials

Flag link:

FDA quickly follows a voluntary pause for CAR-T 2.0 with a clinical hold to investigate 2 patient deaths

FDA quickly follows a voluntary pause for CAR-T 2.0 with a clinical hold to investigate 2 patient deaths

Endpoints

Flag link:

Baxter warns of potential blockages in infusion pumps linked to 3 deaths

Baxter warns of potential blockages in infusion pumps linked to 3 deaths

Fierce Biotech

Baxter International

Flag link:

Pages